Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGIF receptor - Heparin complex

被引:87
作者
Harmer, NJ
Ilag, LL
Mulloy, B
Pellegrini, L
Robinson, CV
Blundell, TI
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
[2] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[3] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
fibroblast growth factor; mass spectrometry; receptor complex; heparin; heparan sulphate;
D O I
10.1016/j.jmb.2004.04.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 22 members of the fibroblast growth factor (FGF) family have been implicated in cell proliferation, differentiation, survival, and migration. They are required for both development and maintenance of vertebrates, demonstrating an exquisite pattern of affinities for both protein and proteoglycan receptors. Recent crystal structures have suggested two models for the complex between FGFs, FGF receptors (FGFRs) and the proteoglycan heparan sulphate that mediates signalling, and have provided insight into how FGFs show differing affinities for the range of FGFRs. However, the physiological relevance of the two different models has not been made clear. Here, we demonstrate that the two complexes can be prepared from the same protein components, confirming that neither complex is the product of misfolded protein samples. Analyses of the complexes with mass spectrometry and analytical ultracentrifugation show that the species observed are consistent with the crystal structures formed using the two preparation protocols. This analysis supports the contention that both of the crystal structures reflect the state of the molecules in solution. Mass spectrometry of the complexes suggests that the stoichiometry of the complexes, is 2 FGF1 :2 FGFR2: 1 heparin, regardless of the method used to prepare the complexes. These observations suggest that the two proposed complex architectures may both have relevance to the formation of an in vivo signalling complex, with a combination of the two interactions contributing to the formation of a larger focal complex. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:821 / 834
页数:14
相关论文
共 43 条
[1]   Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis [J].
Bellosta, P ;
Iwahori, A ;
Plotnikov, AN ;
Eliseenkova, AV ;
Basilico, C ;
Mohammadi, M .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (17) :5946-5957
[2]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[3]   Fibroblast growth factor receptors: lessons from the genes [J].
Burke, D ;
Wilkes, D ;
Blundell, TL ;
Malcolm, S .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (02) :59-62
[4]  
CRUMLEY G, 1991, ONCOGENE, V6, P2255
[5]  
DeLano W., PYMOL MOL GRAPHICS S
[6]   Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts [J].
Delehedde, M ;
Lyon, M ;
Gallagher, JT ;
Rudland, PS ;
Fernig, DG .
BIOCHEMICAL JOURNAL, 2002, 366 (01) :235-244
[7]   Structure of a heparin-linked biologically active dimer of fibroblast growth factor [J].
DiGabriele, AD ;
Lax, I ;
Chen, DI ;
Svahn, CM ;
Jaye, M ;
Schlessinger, J ;
Hendrickson, WA .
NATURE, 1998, 393 (6687) :812-817
[8]   3-DIMENSIONAL STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH-FACTOR [J].
ERIKSSON, AE ;
COUSENS, LS ;
WEAVER, LH ;
MATTHEWS, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) :3441-3445
[9]   The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity [J].
Harmer, NJ ;
Pellegrini, L ;
Chirgadze, D ;
Fernandez-Recio, J ;
Blundell, TL .
BIOCHEMISTRY, 2004, 43 (03) :629-640
[10]   Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces [J].
Hecht, HJ ;
Adar, R ;
Hofmann, B ;
Bogin, O ;
Weich, H ;
Yayon, A .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2001, 57 :378-384